Clivatuzumab tetraxetan

DB33707Investigational

Clivatuzumab tetraxetan: Overview.

Mechanism
Curator reviewed
Code names
HPAM-4 · IgG-DOTA

Resolves to

Compound
UNII1D1F7UG35JChEMBLCHEMBL3301586
Targets
P15941MUC1

What you can answer from here — as of August 28, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
2Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with Clivatuzumab tetraxetan, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In